Abstract
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
Schwab, Claire; Nebral, Karin; Chilton, Lucy; Leschi, Cristina; Waanders, Esmé; Boer, Judith M; Žaliová, Markéta; Sutton, Rosemary; Öfverholm, Ingegerd Ivanov; Ohki, Kentaro; Yamashita, Yuka; Groeneveld-Krentz, Stefanie; Froňková, Eva; Bakkus, Marleen; Tchinda, Joelle; da Conceição Barbosa, Thayana; Fazio, Grazia; Mlynarski, Wojciech; Pastorczak, Agata; Cazzaniga, Giovanni; Pombo-de-Oliveira, Maria S; Trka, Jan; Kirschner-Schwabe, Renate; Imamura, Toshihiko; Barbany, Gisela; Stanulla, Martin; Attarbaschi, Andishe; Panzer-Grümayer, Renate; Kuiper, Roland P; den Boer, Monique L; Cavé, Hélène; Moorman, Anthony V; Harrison, Christine J; Strehl, Sabine (2017). Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? Blood advances, 1(19):1473-1477.
Abstract
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Hematology |
| Language: | English |
| Date: | 22 August 2017 |
| Deposited On: | 16 Jan 2018 07:09 |
| Last Modified: | 13 May 2022 11:56 |
| Publisher: | American Society of Hematology |
| ISSN: | 2473-9529 |
| OA Status: | Gold |
| Free access at: | PubMed ID. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1182/bloodadvances.2017006734 |
| PubMed ID: | 29296789 |
Schwab, Claire